Literature DB >> 11208152

Generation of MHC class I peptide antigens by protein processing in the secretory route by furin.

B C Gil-Torregrosa1, A R Castaño, D López, M Del Val.   

Abstract

Cytosolic degradation of endogenously synthesized proteins by the proteasome and translocation of processed peptides to the endoplasmic reticulum by the transporters associated with antigen presentation constitutes the classical route for antigen presentation by MHC class I proteins. We have previously defined an alternative pathway in the secretory route involving proteolytic maturation of precursor proproteins for chimeric hepatitis B virus secretory core protein HBe containing a class I epitope at its carboxy-terminus. We extend those results by demonstrating that intracellular delivery of the trans-Golgi network protease furin increases both proteolytic maturation and antigen presentation of the chimeric HBe proteins. An additional class I epitope from the HIV envelope gp160 protein was inserted into this COOH-terminal region of two different chimeric HBe proteins. This epitope was also presented to CTL in a transporter-independent manner involving furin, and protein maturation and antigen presentation were also enhanced by furin over-expression. Presentation of this second epitope was restricted by a different class I allele, thus suggesting that antigen presentation by this new pathway may apply to any antigenic epitope and class I molecule. These results define the furin proteolytic maturation pathway of HBe in the secretory route as a general antigen processing route for MHC class I presentation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11208152     DOI: 10.1034/j.1600-0854.2000.010808.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  11 in total

1.  The origin of proteasome-inhibitor resistant HLA class I peptidomes: a study with HLA-A*68:01.

Authors:  Noel García-Medel; Alejandro Sanz-Bravo; Eilon Barnea; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2011-10-03       Impact factor: 5.911

2.  The C terminus of the nucleoprotein of influenza A virus delivers antigens transduced by Tat to the trans-golgi network and promotes an efficient presentation through HLA class I.

Authors:  Francesca Bettosini; Maria Teresa Fiorillo; Adriana Magnacca; Laura Leone; Maria Rosaria Torrisi; Rosa Sorrentino
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 3.  Generation of MHC class I ligands in the secretory and vesicular pathways.

Authors:  Margarita Del Val; Salvador Iborra; Manuel Ramos; Silvia Lázaro
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

4.  Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells.

Authors:  Elena Lorente; Ruth García; Daniel López
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

5.  Insertion of exogenous epitopes in the E3-19K of oncolytic adenoviruses to enhance TAP-independent presentation and immunogenicity.

Authors:  A Rodríguez-García; E Svensson; R Gil-Hoyos; C A Fajardo; L A Rojas; M Arias-Badia; A S I Loskog; R Alemany
Journal:  Gene Ther       Date:  2015-05-21       Impact factor: 5.250

6.  Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation.

Authors:  Elena Lorente; Ruth García; Carmen Mir; Alejandro Barriga; François A Lemonnier; Manuel Ramos; Daniel López
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

7.  Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes.

Authors:  Daniel López; Margarita García-Calvo; Geoffrey L Smith; Margarita Del Val
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

Review 8.  Antigen presentation by MHC-E: a putative target for vaccination?

Authors:  Linda Voogd; Paula Ruibal; Tom H M Ottenhoff; Simone A Joosten
Journal:  Trends Immunol       Date:  2022-03-31       Impact factor: 19.709

Review 9.  VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

Authors:  Pierre Leblanc; Leonard Moise; Cybelle Luza; Kanawat Chantaralawan; Lynchy Lezeau; Jianping Yuan; Mary Field; Daniel Richer; Christine Boyle; William D Martin; Jordan B Fishman; Eric A Berg; David Baker; Brandon Zeigler; Dale E Mais; William Taylor; Russell Coleman; H Shaw Warren; Jeffrey A Gelfand; Anne S De Groot; Timothy Brauns; Mark C Poznansky
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

10.  Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells.

Authors:  Elena Lorente; Susana Infantes; Eilon Barnea; Ilan Beer; Alejandro Barriga; Noel García-Medel; Fátima Lasala; Mercedes Jiménez; Arie Admon; Daniel López
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.